| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥3.0B | ¥3.5B | -13.9% |
| Operating Income | ¥0.5B | ¥0.9B | -45.1% |
| Ordinary Income | ¥0.5B | ¥0.9B | -45.9% |
| Net Income | ¥0.3B | ¥-0.2B | +322.3% |
| ROE | 2.9% | -0.9% | - |
Q1 FY2026 results show revenue of 3.0B yen (YoY -13.9%), operating income of 0.5B yen (YoY -45.1%), ordinary income of 0.5B yen (YoY -45.9%), and net income of 0.3B yen (YoY +322.3%, turning from prior year loss of -0.2B yen to profit). The net income improvement was achieved despite operating profit decline, primarily due to elimination of prior year extraordinary losses. However, current quarter recorded 1.1B yen in extraordinary losses, significantly impacting bottom line. Gross margin remains healthy at 54.9%, but operating margin compressed to 16.6% due to revenue decline and SGA expense burden of 1.2B yen (38.3% of revenue).
Revenue declined 13.9% YoY to 3.0B yen, driven by significant contraction in the core Commissioned Distillation segment. Commissioned Distillation revenue fell from 3.4B yen to 2.8B yen (external revenue), with contract processing declining from 249M yen to 184M yen (-26.1%) YoY, while R&D support services increased from 89M yen to 94M yen (+5.9%). Plant Services segment showed revenue growth, increasing from 133M yen to 243M yen (+83.0%) in external revenue. Operating profit declined 45.1% to 0.5B yen, with the decline exceeding revenue decline due to operating deleverage. Commissioned Distillation segment profit decreased from 181M yen to 132M yen (-27.0%), while Plant Services segment loss narrowed from -20M yen to -1M yen, approaching breakeven. Corporate overhead expenses increased from 69M yen to 81M yen (+16.8%), further pressuring operating margins. The extraordinary loss of 1.1B yen in the current quarter represents a non-recurring factor impacting net income, though net income still turned positive from prior year loss of -0.2B yen. This represents a revenue down/profit down (operating basis) pattern, though net income improved due to base effect from prior year extraordinary losses.
Commissioned Distillation is the core business, generating 2.8B yen in revenue (92.1% of total) with operating profit of 1.3B yen and segment margin of 47.5%. This segment comprises contract processing (184M yen) and R&D support services (94M yen). Segment profit declined 27.0% YoY despite maintaining high margins, reflecting volume decline in contract processing. Plant Services generated 0.4B yen in revenue (7.9% of total) with operating loss of -0.0B yen (margin -1.7%). This segment showed significant revenue growth (+83.0% YoY) and loss improvement from -20M yen to near breakeven, suggesting improving operational efficiency. The margin differential between segments is substantial: Commissioned Distillation operates at 47.5% while Plant Services remains marginally loss-making, indicating different business economics. Corporate costs of 81M yen are allocated outside segment results.
[Profitability] ROE of 2.9% represents low return on equity capital, though net profit margin of 11.4% indicates healthy bottom-line profitability. Operating margin of 16.6% declined from prior year 25.9% (-9.3pt), reflecting operating deleverage from revenue decline and SGA expense rigidity. Gross margin remained strong at 54.9%, indicating pricing power and production efficiency in core operations. [Cash Quality] Cash and deposits of 3.0B yen decreased 5.7B yen (-65.8%) YoY, representing significant cash consumption. Cash coverage of current liabilities stands at 1.13x, declining from 3.30x YoY. Trade receivables increased 1.9B yen to 2.8B yen (+191.1% YoY), indicating significant working capital deterioration with receivables collection extending to 342 days. Inventories totaled 0.3B yen with finished goods of 0.3B yen, raw materials of 0.3B yen, and work in process of 0.7B yen. [Investment Efficiency] Asset turnover of 0.21x is low, contributing to weak ROE despite positive profit margins. Return on assets of 2.4% and return on invested capital estimated at 3.9% indicate suboptimal capital efficiency. Property, plant and equipment totals 7.1B yen, representing 48.8% of total assets, reflecting capital-intensive manufacturing operations. [Financial Health] Equity ratio of 81.4% is very strong, indicating conservative capital structure. Current ratio of 275.9% and quick ratio of 266.3% suggest adequate liquidity coverage, though absolute cash position weakened substantially. Debt-to-equity ratio of 0.23x reflects minimal leverage. Retained earnings of 10.3B yen provide substantial equity cushion.
Cash and deposits decreased 5.7B yen YoY to 3.0B yen, representing 65.8% decline and indicating significant cash consumption during the quarter. The primary driver appears to be substantial working capital deterioration, with trade receivables increasing 1.9B yen to 2.8B yen (+191.1% YoY), suggesting delayed customer collections significantly absorbed cash. Trade payables increased 0.7B yen (+1,791.9% YoY from low base), providing partial working capital financing offset. The combination of operating profit of 0.5B yen against cash decline of 5.7B yen indicates material cash outflows beyond operations, potentially including capital allocation activities as suggested by treasury stock changes of -4.6B yen. Working capital efficiency deteriorated substantially with receivables collection extending to 342 days (DSO warning level), while payables turnover of 193 days indicates extended supplier payment terms being utilized. The dramatic shift in working capital composition from cash to receivables warrants close monitoring of collection risk and customer credit quality. Short-term debt coverage ratio of 1.13x declined from 3.30x, indicating reduced financial flexibility despite strong equity ratio of 81.4%.
Ordinary income of 0.5B yen is closely aligned with operating income of 0.5B yen, indicating minimal non-operating income impact. Non-operating income and expenses both totaled 0.0B yen (rounded), representing negligible contribution to earnings. The gap between ordinary income of 0.5B yen and net income of 0.3B yen reflects extraordinary losses of 1.1B yen recorded in the quarter, representing non-recurring factors. These extraordinary losses significantly impacted final earnings quality, as net income would have been approximately 1.4B yen absent these charges. Income tax expense of 0.2B yen against profit before tax of 0.5B yen implies effective tax rate around 35-40%. The improvement in net income from -0.2B yen loss to +0.3B yen profit (+322.3% YoY) reflects base effect from prior year extraordinary items rather than operating improvement. Operating cash flow data is not disclosed for quarterly period, but balance sheet analysis reveals significant working capital absorption through receivables buildup of 1.9B yen and cash decline of 5.7B yen, suggesting earnings are not converting to cash. The 342-day receivables collection period raises concerns about earnings realization timing and potential credit quality issues. Core operating profitability remains healthy with gross margin of 54.9% and operating margin of 16.6%, but working capital deterioration indicates earnings quality concerns from cash conversion perspective.
Full-year guidance projects revenue of 12.4B yen (YoY +5.3%), operating income of 1.4B yen (YoY +0.7%), and ordinary income of 1.4B yen (YoY +0.9%). Q1 progress rate against full-year guidance is 24.4% for revenue, 35.8% for operating income, and 35.9% for ordinary income. Revenue progress is slightly below standard 25% quarterly run rate, while operating income progress is ahead of 25% standard pace. However, the ahead-schedule operating income achievement appears influenced by seasonal factors or timing, as YoY operating income declined 45.1% in Q1 despite full-year guidance projecting only 0.7% growth. This suggests management expects significant H2-weighted recovery, requiring 65M yen monthly operating income average for remaining three quarters versus 50M yen achieved in Q1. The revenue recovery to achieve 12.4B yen annual target requires quarterly average of 3.1B yen for remaining three quarters, representing modest acceleration from Q1's 3.0B yen. No forecast revision was announced this quarter. The forecast assumes continued strength in R&D support services and Plant Services segments, with recovery in contract processing operations that declined 26.1% YoY in Q1.
Annual dividend forecast is 0.00 yen per share, indicating no dividend payment planned for the fiscal year. This represents suspension from any prior dividend policy and reflects management prioritization of cash conservation given working capital pressures and cash position decline of 5.7B yen (-65.8%) observed in Q1. The dividend suspension is prudent given net income of 0.3B yen (34M yen) against estimated share count of approximately 1.0M shares would support maximum 34 yen per share payout, but cash flow constraints and extraordinary loss impacts make distributions unfeasible. No share buyback activity is disclosed for the quarter, though treasury stock changes suggest prior period repurchase activity. Total return ratio is 0% given no dividends or current buybacks planned.
Revenue concentration risk in Commissioned Distillation segment, which represents 92.1% of total revenue, creates vulnerability to customer concentration, industry cyclicality, or pricing pressure. Any further decline in contract processing volume, which fell 26.1% YoY in Q1, would significantly impact consolidated profitability given segment's 47.5% operating margin contribution.
Working capital deterioration risk with trade receivables increasing 191.1% YoY to 2.8B yen and days sales outstanding extending to 342 days, indicating potential customer credit quality issues or contract payment term extensions. Combined with cash decline of 5.7B yen (-65.8%), this creates liquidity pressure despite strong equity ratio of 81.4%.
Extraordinary loss recurrence risk as current quarter recorded 1.1B yen in extraordinary losses after prior year also experienced losses, suggesting potential structural issues or asset impairment patterns. The nature and recurrence probability of these charges significantly impacts normalized earnings power and cash generation sustainability.
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE 2.9% closely aligns with industry median 3.1% (2025-Q1, n=8), indicating peer-level equity returns despite low absolute level. Operating margin of 16.6% significantly exceeds industry median of 6.8% (IQR: 2.9%-9.0%), demonstrating superior operational efficiency. Net profit margin of 11.4% also surpasses industry median of 5.9% (IQR: 3.3%-7.7%), reflecting strong cost structure relative to peers. Financial Health: Equity ratio of 81.4% substantially exceeds industry median of 43.9% (IQR: 28.4%-50.7%), indicating conservative capitalization and minimal financial leverage relative to manufacturing sector peers. Current ratio of 275.9% also exceeds industry median of 1.87x, though this partially reflects receivables buildup rather than pure liquidity strength. Efficiency: Asset turnover of 0.21x exceeds industry median of 0.17 (IQR: 0.16-0.23), suggesting slightly above-average asset utilization despite low absolute level. However, receivables turnover of 342 days significantly exceeds industry median of 269 days (IQR: 168-456 days), indicating below-peer working capital efficiency. Revenue declined 13.9% YoY versus industry median growth of +13.2% (IQR: +2.5% to +28.5%), placing the company in bottom quartile for top-line momentum. ※ Industry: Manufacturing (8 companies), Comparison: 2025-Q1 period, Source: Proprietary analysis
Superior margin structure with operating margin of 16.6% (vs. industry median 6.8%) and net margin of 11.4% (vs. industry median 5.9%) demonstrates competitive positioning and pricing power in specialized contract manufacturing and R&D support services. Gross margin sustainability at 54.9% indicates differentiated value proposition and limited commoditization risk in core Commissioned Distillation segment.
Working capital management deterioration presents immediate concern, with receivables increasing 191.1% YoY to 342-day collection cycle (vs. industry median 269 days) while cash declined 65.8% to 3.0B yen. This shift from liquid assets to receivables suggests either customer payment term extensions or collection challenges that could impair cash generation despite strong reported profitability. The company's extremely conservative balance sheet (81.4% equity ratio vs. industry median 43.9%) provides buffer, but near-term working capital recovery is critical for validating earnings quality and achieving full-year guidance requiring 65M yen quarterly operating profit average.
Dividend suspension to 0 yen reflects prudent capital allocation given cash constraints, though it eliminates shareholder yield. Full-year guidance implies significant H2 recovery (Q1 operating income 0.5B yen vs. 1.4B yen annual target requires 0.9B yen in remaining three quarters), creating execution risk. Investors should monitor Q2 receivables collection trends, contract processing volume recovery, and cash flow normalization as key indicators of guidance achievability and business model sustainability beyond current working capital cycle disruption.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.